#52 Full-blown Mystical Experiences From The God Molecule 5-MeO-DMT
28m
·
LET'S TALK PLANT MEDICINE: Cannabis, Psychedelics & Pharmaceutics with Dr. O
·
Today on Let's Talk Plant Medicine With Dr. O we talk with the President of F.I.V.E., Victoria Wueschner. Victoria's team recently launched F.I.V.E. this summer as the first educational platform designed to help individuals make informed decisions when choosing to work with 5-MeO-DMT. Kaivalya Kollectiv, the parent company of F.I.V.E has been offering professionally guided experiences with synthetic 5-MeO-DMT. 5-MeO-DMT is called The God Molecule because it facilitates full-blown mystical experiences, including an alleged communion with some higher-order, divine consciousness. It is the most powerful psychedelic on the planet.
The F.I.V.E website states: “As the psychedelic renaissance continues to expand, 5-MeO-DMT is quickly growing in popularity. In the current 5-MeO-DMT landscape, it is becoming increasingly important for everyone, including first-time seekers of this compound, seasoned psychonauts, and even facilitators, to have access to the resources needed to cultivate safe and effective experiences.” Victoria's company also operates Tandava Retreats, a 5-MeO-DMT retreat center in Tepoztlan, Mexico, whose staff has served over 2,000 guests since 2016. Many of those seekers are seeking a healthier state of mind, personal growth, and improved relationships with themselves, including but not limited to entrepreneurs, artists, and everyday people seeking a deeper connection with themselves.
For more Let's Talk Plant Medicine With Dr. O go to CannabisRadio.com
The episode #52 Full-blown Mystical Experiences From The God Molecule 5-MeO-DMT from the podcast LET'S TALK PLANT MEDICINE: Cannabis, Psychedelics & Pharmaceutics with Dr. O has a duration of
28:16. It was first published
More episodes from LET'S TALK PLANT MEDICINE: Cannabis, Psychedelics & Pharmaceutics with Dr. O
#61 How Cannabis Can Be Effective for Cancer Pain
Today's guest is Dr. Brooke Worster a Cancer Pain Management Doctor at Jefferson Health in Philadelphia and a cannabis researcher with Thomas Jefferson University. Her research interests focus on improving the quality of life for patients with serious illnesses.
This includes both the impact, risks, and benefits of cannabis compared to other prescription pharmacotherapy for pain and other burdensome symptoms as well as how to quantify and maximize the benefits of team-based interprofessional interactions for patients and their families.
#60 How Lumenate Is the App "Tat Makes You Trip"
Lumenate is a pioneering app that uses sound and light to change brain rhythms in ways similar to psychedelics and highly experienced meditators, and brain imaging researchers at Imperial College London and as well as researchers in Berlin.
Our guests have talked about what psychedelic experiences and Lumenate appear to have in common. They talked about Increased brain signal complexity, reduced activity in the default mode network, increased functional connectivity between different brain regions, and reductions in peak alpha brainwaves.
They have ongoing trials underway in London which "aims to uncover neural mechanisms of visual imagery induced by Lumenate, using high-density EEG. The research also aims at comparing psychedelic experiences induced by DMT and Lumenate, by exploring the psychological and biological mechanisms of both altered states of consciousness”.
#59 Transitional Cannabis Research and Clinical Trials
Dr. Cornblatt is a Johns Hopkins University School of Medicine Graduate with a Ph.D. in Pharmacology and Molecular Sciences and a postdoctoral fellowship from the Johns Hopkins Bloomberg School of Public Health, Environmental Health Sciences Division of Toxicology.
Dr. Cornblatt has served as Director of Consumer Clinical Research and Science and as Medical Director at Nutramax Laboratories Consumer Care, Inc. In this role, Dr. Cornblatt developed novel nutraceutical formulations, designed both in vitro and clinical studies in support of products, and summarized both supporting laboratory and clinical research for healthcare workers and consumers.
His most recent development has been a novel line of products (and 18 related clinical trials) that deliver the essential ingredients needed to support the production of sulforaphane, a phytochemical with many emerging indications. Dr. Cornblatt is also the inventor of three issued patents and four pending provisional patents focused on plant-based bioactive compounds and health promotion.
#58 Psychedelic Treatment over Traditional Therapeutics?
Silo Pharma merges traditional therapeutics with psychedelic research to develop innovative solutions that address a variety of underserved conditions including Alzheimer’s, Fibromyalgia, Parkinson’s, Multiple Sclerosis (MS), Rheumatoid Arthritis (RA), as well as stress-induced psychiatric disorders (i.e. PTSD) and other debilitating chronic conditions. We talk about the research and the conditions you choose to study in conjunction with psychedelic treatment.
Silo has partnered with several leading academic institutions (the University of California, San Francisco, Columbia University, and the University of Maryland, Baltimore) to facilitate a streamlined regulatory pathway for drug approval. The company has developed a pipeline of proprietary licensed therapeutics that show promise for a range of illnesses and diseases.
Silo Pharma Inc. has begun dosing in its IND-enabling study of a proprietary time-released, topical formulation of ketamine SP-26 designed to treat fibromyalgia. The safety evaluation trial will be conducted by Experimur, a Frontage Company, and intends to evaluate the tolerability of SP-26 to establish a maximum dose in the treatment of this chronic medical condition causing widespread musculoskeletal pain as well as memory issues, sleep difficulties, and fatigue.
#57 Psychedelic Integration, Mastering Change and The Shadow Tribe
Steven Twohig has been studying an abundance of practices extensively, including mindfulness, business optimization, shadow work and facilitation, Neuro-Linguistic Programming (NLP), hypnotherapy, and leadership dynamics. He recently has been researching psychedelic integration, which is defined as a process in which the patient integrates the insights of their experience into their life, and PHRI is a method of supporting that in the clinical consultation room.
On Steven's website for Mastering Change, he wrote: “miscoding deep in the human mind. This coding is the root cause of all suffering in the world. By doing your shadow work, you are doing the work necessary to change the world. Everything in this reality is a reflection of everything else. If above, so below. So within, so without. You are a reflection of your outside world, just like this world is a reflection of you.” Steven expands on this and much more in today's episode.